Update on primary biliary cirrhosis

Digestive and Liver Disease

Volumn 42, Issue 6, 2010, Pages 401-408

  Invernizzi, Pietro ^a,b   Selmi, Carlo ^a,c   Gershwin, M Eric ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Autoantibodies; Autoimmune cholangitis; Tolerance breakdown

Indexed keywords

ANTINUCLEAR ANTIBODY; MITOCHONDRION ANTIBODY; SEX HORMONE; XENOBIOTIC AGENT; AUTOANTIBODY;

AUTOIMMUNITY; CELLULAR IMMUNITY; DISEASE MODEL; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; FAMILIAL DISEASE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOREACTIVITY; INFECTION; INNATE IMMUNITY; MICROCHIMERISM; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX CHROMOSOME; SEX DIFFERENCE; SHORT SURVEY; T LYMPHOCYTE; ANIMAL; DISEASE COURSE; GENETIC PREDISPOSITION; IMMUNOLOGY; LIVER CIRRHOSIS, BILIARY;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; LIVER CIRRHOSIS, BILIARY; RISK FACTORS; T-LYMPHOCYTES;

EID: 77952741684     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.02.014     Document Type: Short Survey

References (116)

1. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 2005, 353:1261-1273.
2. Gershwin M.E., Mackay I.R. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008, 47:737-745.
3. Invernizzi P. Future directions in genetic for autoimmune diseases. J Autoimmun 2009, 33:1-2.
4. Invernizzi P., Pasini S., Selmi C., et al. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009, 33:12-16.
5. Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun 2009.
6. Oertelt S., Rieger R., Selmi C., et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 2007, 45:659-665.
7. Invernizzi P., Lleo A., Podda M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis 2007, 27:161-172.
8. Invernizzi P., Podda M., Battezzati P.M., et al. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 2001, 34:366-372.
9. Wesierska-Gadek J., Penner E., Battezzati P.M., et al. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 2006, 43:1135-1144.
10. Invernizzi P., Selmi C., Ranftler C., et al. Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 2005, 25:298-310.
11. Gershwin M.E., Selmi C., Worman H.J., et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005, 42:1194-1202.
12. Hudson M., Rojas-Villarraga A., Coral-Alvarado P., et al. Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun 2008, 31:156-159.
13. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237-67.
14. Metcalf J.V., Mitchison H.C., Palmer J.M., et al. Natural history of early primary biliary cirrhosis. Lancet 1996, 348:1399-1402.
15. Lleo A., Invernizzi P., Mackay I.R., et al. Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol 2008, 14:3328-3337.
16. Shimoda S., Harada K., Niiro H., et al. CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis. Hepatology 2009.
17. Lleo A., Selmi C., Invernizzi P., et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 2009, 49:871-879.
18. Marmont A.M. Will hematopoietic stem cell transplantation cure human autoimmune diseases?. J Autoimmun 2008, 30:145-150.
19. Burt R.K., Testori A., Craig R., et al. Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?. J Autoimmun 2008, 30:116-120.
20. Yaniv I., Ash S., Farkas D.L., et al. Consideration of strategies for hematopoietic cell transplantation. J Autoimmun 2009.
21. Invernizzi P., Gershwin M.E. The genetics of human autoimmune disease. J Autoimmun 2009.
22. Lazaridis K.N., Talwalkar J.A. Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. J Clin Gastroenterol 2007, 41:494-500.
23. Selmi C., Mayo M.J., Bach N., et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004, 127:485-492.
24. Invernizzi P., Miozzo M., Battezzati P.M., et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004, 363:533-535.
25. Miozzo M., Selmi C., Gentilin B., et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 2007, 46:456-462.
26. Invernizzi P. Role of X chromosome defects in primary biliary cirrhosis. Hepatol Res 2007, 37(Suppl. 3):S384-S388.
27. Invernizzi P., Pasini S., Selmi C., et al. Skewing of X chromosome inactivation in autoimmunity. Autoimmunity 2008, 41:272-277.
28. Sanchez-Pernaute O., Ospelt C., Neidhart M., et al. Epigenetic clues to rheumatoid arthritis. J Autoimmun 2008, 30:12-20.
29. Invernizzi P., Selmi C., Mackay I.R., et al. From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2005, 3:401-410.
30. Invernizzi P., Gershwin M.E. The genetic basis of primary biliary cirrhosis: premises, not promises. Gastroenterology 2008, 135:1044-1047.
31. Invernizzi P., Selmi C., Poli F., et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 2008, 48:1906-1912.
32. Donaldson P.T., Baragiotta A., Heneghan M.A., et al. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 2006, 44:667-674.
33. Hirschfield G.M., Liu X., Xu C., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009.
34. Invernizzi P., Battezzati P.M., Crosignani A., et al. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol 2003, 38:401-406.
35. Van de Water J., Ishibashi H., Coppel R.L., et al. Molecular mimicry and primary biliary cirrhosis: premises not promises. Hepatology 2001, 33:771-775.
36. Christen U., Hintermann E., Holdener M., et al. Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?. J Autoimmun 2009.
37. Long S.A., Quan C., Van de Water J., et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001, 167:2956-2963.
38. Selmi C., Gershwin M.E. Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol 2004, 16:406-410.
39. Selmi C., Balkwill D.L., Invernizzi P., et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003, 38:1250-1257.
40. Mattner J., Savage P.B., Leung P., et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 2008, 3:304-315.
41. Selmi C., Ross S.R., Ansari A.A., et al. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology 2004, 127:493-501.
42. McDermid J., Chen M., Li Y., et al. Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Aliment Pharmacol Ther 2007, 26:587-595.
43. Selmi C., Gershwin M.E. The retroviral myth of primary biliary cirrhosis: is this (finally) the end of the story?. J Hepatol 2009, 51:412-413.
44. Tanaka A., Lindor K., Gish R., et al. Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis. Hepatology 1999, 30:833-838.
45. Invernizzi P., De Andreis C., Sirchia S.M., et al. Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol 2000, 122:418-422.
46. McCombe P.A., Greer J.M., Mackay I.R. Sexual dimorphism in autoimmune disease. Curr Mol Med 2009, 9:1058-1079.
47. Alvaro D., Invernizzi P., Onori P., et al. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 2004, 41:905-912.
48. Larizza D., Calcaterra V., Martinetti M. Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun 2009, 33:25-30.
49. Persani L., Rossetti R., Cacciatore C., et al. Primary ovarian insufficiency: X chromosome defects and autoimmunity. J Autoimmun 2009, 33:35-41.
50. Pessach I.M., Notarangelo L.D. X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. J Autoimmun 2009, 33:17-24.
51. Carrel L., Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434:400-404.
52. Invernizzi P., Miozzo M., Selmi C., et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005, 175:575-578.
53. Invernizzi P., Miozzo M., Oertelt-Prigione S., et al. X monosomy in female systemic lupus erythematosus. Ann N Y Acad Sci 2007, 1110:84-91.
54. Sawalha A.H., Harley J.B., Scofield R.H. Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes. J Autoimmun 2009, 33:31-34.
55. Ozbalkan Z., Bagislar S., Kiraz S., et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 2005, 52:1564-1570.
56. Brix T.H., Knudsen G.P., Kristiansen M., et al. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab 2005, 90:5949-5953.
57. Brix T.H., Hansen P.S., Bennedbak F.N., et al. X Chromosome inactivation pattern is not associated with interindividual variations in thyroid volume: a study of euthyroid Danish female twins. Twin Res Hum Genet 2009, 12:502-506.
58. Chuang Y.H., Ridgway W.M., Ueno Y., et al. Animal models of primary biliary cirrhosis. Clin Liver Dis 2008, 12:333-347. ix.
59. Wakabayashi K., Lian Z.X., Moritoki Y., et al. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology 2006, 44:1240-1249.
60. Oertelt S., Lian Z.X., Cheng C.M., et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 2006, 177:1655-1660.
61. Moritoki Y., Zhang W., Tsuneyama K., et al. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology 2009, 136:1037-1047.
62. Irie J., Wu Y., Wicker L.S., et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 2006, 203:1209-1219.
63. Amano K., Leung P.S., Xu Q., et al. Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J Immunol 2004, 172:6444-6452.
64. Leung P.S., Park O., Tsuneyama K., et al. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol 2007, 179:2651-2657.
65. Wakabayashi K., Lian Z.X., Leung P.S., et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008, 48:531-540.
66. Lan R.Y., Salunga T.L., Tsuneyama K., et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 2009, 32:43-51.
67. Shimoda S., Nakamura M., Ishibashi H., et al. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 1995, 181:1835-1845.
68. Shimoda S., Harada K., Niiro H., et al. Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology 2008, 47:958-965.
69. Shimoda S., Ishikawa F., Kamihira T., et al. Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory. Gastroenterology 2006, 131:606-618.
70. Shimoda S., Nakamura M., Ishibashi H., et al. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology 2003, 124:1915-1925.
71. Shimoda S., Nakamura M., Shigematsu H., et al. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 2000, 31:1212-1216.
72. Kita H., Naidenko O.V., Kronenberg M., et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002, 123:1031-1043.
73. Barak V., Selmi C., Schlesinger M., et al. Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. J Autoimmun 2009, 33:178-182.
74. Shimoda S., Miyakawa H., Nakamura M., et al. CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun 2008, 31:110-115.
75. Yang G.X., Lian Z.X., Chuang Y.H., et al. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 2008, 47:1974-1982.
76. Hsu W., Zhang W., Tsuneyama K., et al. Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice. Hepatology 2009, 49:133-140.
77. Kita H., Matsumura S., He X.S., et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 2002, 109:1231-1240.
78. Brusko T.M., Putnam A.L., Bluestone J.A. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 2008, 223:371-390.
79. Jordan M.A., Baxter A.G. The genetics of immunoregulatory T cells. J Autoimmun 2008, 31:237-244.
80. Aoki C.A., Roifman C.M., Lian Z.X., et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 2006, 27:50-53.
81. Zhang W., Sharma R., Ju S.T., et al. Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology 2009, 49:545-552.
82. Lan R.Y., Cheng C., Lian Z.X., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006, 43:729-737.
83. Sasaki M., Ikeda H., Sawada S., et al. Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis. J Clin Pathol 2007, 60:1102-1107.
84. Sakaki M., Hiroishi K., Baba T., et al. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis. Hepatol Res 2008, 38:354-361.
85. Selmi C., Zuin M., Gershwin M.E. The unfinished business of primary biliary cirrhosis. J Hepatol 2008, 49:451-460.
86. Kikuchi K., Lian Z.X., Yang G.X., et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 2005, 128:304-312.
87. Moritoki Y., Lian Z.X., Wulff H., et al. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology 2007, 45:314-322.
88. Mao T.K., Lian Z.X., Selmi C., et al. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 2005, 42:802-808.
89. Chuang Y.H., Lian Z.X., Yang G.X., et al. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology 2008, 47:571-580.
90. Zigmond E., Shalev Z., Pappo O., et al. NKT lymphocyte polarization determined by microenvironment signaling: a role for CD8+ lymphocytes and beta-glycosphingolipids. J Autoimmun 2008, 31:188-195.
91. Lleo A., Invernizzi P., Gao B., et al. Definition of human autoimmunity - autoantibodies versus autoimmune disease. Autoimmun Rev 2009.
92. Gershwin M.E., Mackay I.R., Sturgess A., et al. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987, 138:3525-3531.
93. Ishibashi H., Shimoda S., Gershwin M.E. The immune response to mitochondrial autoantigens. Semin Liver Dis 2005, 25:337-346.
94. Oertelt S., Roman R., Selmi C., et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA negative PBC. Hepatology 2007, 45:659-665.
95. Invernizzi P., Crosignani A., Battezzati P.M., et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 1997, 25:1090-1095.
96. Muratori P., Muratori L., Ferrari R., et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 2003, 98:431-437.
97. Rigopoulou E.I., Davies E.T., Pares A., et al. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 2005, 54:528-532.
98. Yang W.H., Yu J.H., Nakajima A., et al. Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?. Clin Gastroenterol Hepatol 2004, 2:1116-1122.
99. Ardesjo B., Hansson C.M., Bruder C.E., et al. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases. J Autoimmun 2008, 30:273-282.
100. Itoh S., Ichida T., Yoshida T., et al. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 1998, 13:257-265.
101. Miyachi K., Hankins R.W., Matsushima H., et al. Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J Autoimmun 2003, 20:247-254.
102. Invernizzi P., Wesierska-Gadek J., Battezzati P.M., et al. Prognostic value of autoantibodies against proteins of nuclear pore complexes (anti-NPCs) in early primary biliary cirrhosis (PBC). J Hepatol 2004, 40:159-160.
103. Nakamura M., Shimizu-Yoshida Y., Takii Y., et al. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol 2005, 42:386-392.
104. Nakamura M., Kondo H., Mori T., et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007, 45:118-127.
105. Ayres R.C., Neuberger J.M., Shaw J., et al. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Gut 1993, 34:1245-1249.
106. Saidman S.L., Duquesnoy R.J., Zeevi A., et al. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology 1991, 13:239-246.
107. Tanaka A., Nalbandian G., Leung P.S., et al. Mucosal immunity and primary biliary cirrhosis: presence of antimitochondrial antibodies in urine. Hepatology 2000, 32:910-915.
108. Reynoso-Paz S., Leung P.S., Van De Water J., et al. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis. Hepatology 2000, 31:24-29.
109. Matsumura S., Van De Water J., Leung P., et al. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology 2004, 39:1415-1422.
110. Lleo A., Selmi C., Invernizzi P., et al. The consequences of apoptosis in autoimmunity. J Autoimmun 2008, 31:257-262.
111. Odin J.A., Huebert R.C., Casciola-Rosen L., et al. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 2001, 108:223-232.
112. Allina J., Stanca C.M., Garber J., et al. Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun 2008, 30:238-245.
113. Padgett K.A., Lan R.Y., Leung P.C., et al. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun 2009, 32:246-253.
114. Sasaki M., Ikeda H., Nakanuma Y. Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study. J Autoimmun 2008, 31:73-78.
115. Shoenfeld Y., Selmi C., Zimlichman E., et al. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008, 31:325-330.
116. Salas J.T., Banales J.M., Sarvide S., et al. Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 2008, 134:1482-1493.